3647 results for «604»
3647 results
GulfPCR-GIM 2018 Opening Ceremony
19 Dec 2018 – From GulfPCR-GIM 2018
Find out about the course highlights, course directors and the scientific programme presented at GulfPCR-GIM 2018 in Dubai!
GulfPCR-GIM 2018 Award and Closing Ceremony
20 Dec 2018 – From GulfPCR-GIM 2018
Consult the closing ceremony of GulfPCR-GIM 2018 and find out who the Best Clinical Case award winner is!
For additional reading, also consult the resource on "How would you treat these challenging cases in your lab?"
PCR Tokyo Valves 2019 Opening Ceremony
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to discover the slides of PCR Tokyo Valves 2019 Opening Ceremony, a course which is expanding to become the major Asian forum in valvular interventions.
Closing Ceremony - PCR Tokyo Valves 2019
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to discover the slides of the PCR Tokyo Valves 2019 closing ceremony, including the best clinical case presenters awards.
Which AF patients may benefit from LAA closure?
02 Jul 2026
Martin Bergmann reviews the evolving evidence for LAAC, examining how recent landmark trials such as OPTION, CLOSURE‑AF and CHAMPION‑AF are reshaping patient selection and expanding the role of LAAC across a broader spectrum of patients with atrial fibrillation.
Author
Future directions of drug-coated balloon angioplasty
06 Feb 2025
Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.
Author
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
